Chao Li

机构：Central South University, Guiyang Medical University, University of Electronic Science and Technology of China, Shandong University, Shanxi Medical University, Anhui Medical University, Quzhou City People's Hospital, Sichuan Cancer Hospital, Henan Cancer Hospital, Third Xiangya Hospital, Ministry of Education · ORCID：0009-0004-9928-3924

发表论文 49 篇 · 总被引 1210 次 · h-index 16

代表论文

• Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma (2023 · Computational and Structural Biotechnology Journal · 被引 28)
• METTL3 mediated m6A modification of HKDC1 promotes renal injury and inflammation in lead nephropathy (2025 · International Journal of Biological Sciences · 被引 11)
• Aurantiamide mitigates acute kidney injury by suppressing renal necroptosis and inflammation via GRPR-dependent mechanism (2024 · International Immunopharmacology · 被引 9)
• Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma (2024 · British Journal of Cancer · 被引 9)
• MPZL1 Promotes Lung Adenocarcinoma Progression by Enhancing Tumor Proliferation, Invasion, Migration, and Suppressing Immune Function via Transforming Growth Factor-β1 (2023 · Human Gene Therapy · 被引 8)
• IGF-Binding Protein 7 and Cadmium-Induced Hepatorenal Fibrosis (2025 · Journal of the American Society of Nephrology · 被引 7)